Cargando…

Peripheral serum metabolomic profiles inform central cognitive impairment

The incidence of Alzheimer's disease (AD) increases with age and is becoming a significant cause of worldwide morbidity and mortality. However, the metabolic perturbation behind the onset of AD remains unclear. In this study, we performed metabolite profiling in both brain (n = 109) and matchin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jingye, Wei, Runmin, Xie, Guoxiang, Arnold, Matthias, Kueider-Paisley, Alexandra, Louie, Gregory, Mahmoudian Dehkordi, Siamak, Blach, Colette, Baillie, Rebecca, Han, Xianlin, De Jager, Philip L., Bennett, David A., Kaddurah-Daouk, Rima, Jia, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441317/ https://www.ncbi.nlm.nih.gov/pubmed/32820198 http://dx.doi.org/10.1038/s41598-020-70703-w

Ejemplares similares

Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression
por: Nho, Kwangsik, et al.
Publicado: (2021)

Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers
por: Nho, Kwangsik, et al.
Publicado: (2019)

Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts
por: St. John-Williams, Lisa, et al.
Publicado: (2019)

Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome
por: Arnold, Matthias, et al.
Publicado: (2020)

Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism
por: Borkowski, Kamil, et al.
Publicado: (2023)

Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer’s disease and progressive supranuclear palsy
por: Batra, Richa, et al.
Publicado: (2023)

Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety—A Role for Bile Acids
por: MahmoudianDehkordi, Siamak, et al.
Publicado: (2022)

Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer’s Disease
por: Baloni, Priyanka, et al.
Publicado: (2020)

Circulating lipid profiles are associated with cross-sectional and longitudinal changes of central biomarkers for Alzheimer’s disease
por: Kim, Jun Pyo, et al.
Publicado: (2023)

The Metabolome-Wide Signature of Major Depressive Disorder
por: Jansen, Rick, et al.
Publicado: (2023)

Targeted metabolomics and medication classification data from participants in the ADNI1 cohort
por: St John-Williams, Lisa, et al.
Publicado: (2017)

Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification
por: Borkowski, Kamil, et al.
Publicado: (2021)

Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer’s disease
por: Baloni, Priyanka, et al.
Publicado: (2022)

Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression
por: MahmoudianDehkordi, Siamak, et al.
Publicado: (2021)

Metabolic Profiling of Patients with Schizophrenia
por: Kaddurah-Daouk, Rima
Publicado: (2006)

ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer’s disease
por: Ko, Yi-An, et al.
Publicado: (2022)

Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics
por: Han, Xianlin, et al.
Publicado: (2011)

Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients
por: Bhattacharyya, Sudeepa, et al.
Publicado: (2019)

Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease
por: Borkowski, Kamil, et al.
Publicado: (2021)

Pilot Study of Metabolomic Clusters as State Markers of Major Depression and Outcomes to CBT Treatment
por: Bhattacharyya, Sudeepa, et al.
Publicado: (2019)

Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment
por: Trupp, Miles, et al.
Publicado: (2012)

Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease
por: Horgusluoglu, Emrin, et al.
Publicado: (2021)

Indoxyl sulfate, a gut microbiome-derived uremic toxin, is associated with psychic anxiety and its functional magnetic resonance imaging-based neurologic signature
por: Brydges, Christopher R., et al.
Publicado: (2021)

Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data
por: Jo, Taeho, et al.
Publicado: (2023)

GSimp: A Gibbs sampler based left-censored missing value imputation approach for metabolomics studies
por: Wei, Runmin, et al.
Publicado: (2018)

Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replication
por: Joyce, Jeremiah B., et al.
Publicado: (2021)

Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine
por: Beger, Richard D., et al.
Publicado: (2020)

Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics
por: Shahin, Mohamed H., et al.
Publicado: (2017)

Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology
por: Barupal, Dinesh Kumar, et al.
Publicado: (2019)

Missing Value Imputation Approach for Mass Spectrometry-based Metabolomics Data
por: Wei, Runmin, et al.
Publicado: (2018)

Generation and quality control of lipidomics data for the alzheimer’s disease neuroimaging initiative cohort
por: Barupal, Dinesh Kumar, et al.
Publicado: (2018)

MiMeDB: the Human Microbial Metabolome Database
por: Wishart, David S, et al.
Publicado: (2022)

Best practices and lessons learned from reuse of 4 patient-derived metabolomics datasets in Alzheimer’s disease
por: Tenenbaum, Jessica D., et al.
Publicado: (2018)

Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease
por: Huynh, Kevin, et al.
Publicado: (2020)

Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer’s disease from normal cognitive aging
por: Motsinger-Reif, Alison A, et al.
Publicado: (2013)

Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
por: Varma, Vijay R., et al.
Publicado: (2018)

Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study
por: Kaddurah-Daouk, Rima, et al.
Publicado: (2010)

t(4) Workshop Report(): Quality Assurance of Metabolomics
por: Bouhifd, Mounir, et al.
Publicado: (2015)

Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics
por: McEvoy, Joseph, et al.
Publicado: (2013)

Module-Based Association Analysis for Omics Data with Network Structure
por: Wang, Zhi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_698jnoq198f2277r5j2ilc180h